Gastric Cancer Learner Survey

Question Title

1. To your knowledge, which racial/ethnic group has the highest incidence of gastric cancer?

African American

Asian American

Hispanic American

Caucasian American

Question Title

2. To your knowledge, death from gastric cancer is more likely for patients from which racial/ethnic group?

African American

Asian American

Hispanic American

Caucasian American

Question Title

3. Which racial/ethnic group has a significantly higher survival rate for gastric cancers, regardless of tumor site, stage, and treatment?

African American

Asian American

Hispanic American

Caucasian American

Question Title

4. Which racial/ethnic group has a higher mortality rate for gastric cancers, despite decreasing incidence/mortality of more common cancers, such as breast, prostate, lung, and colorectal?

African American

Asian American

Hispanic American

Caucasian American

Question Title

5. To your knowledge, which of the following racial/ethnic groups has the highest rate of Helicobacter pylori-associated gastric cancers?

African American

Asian American

Hispanic American

Caucasian American

Question Title

6. How aware are you of the published analysis showing that African-American patients with gastric cancer are significantly less likely to receive adjuvant radiotherapy?

Extremely aware

Very aware

Moderately aware

Slightly aware

Not aware at all

Question Title

7. How confident are you in your knowledge of genetic risk factors for gastric cancer?

Extremely confident

Very confident

Moderately confident

Slightly confident

Not at all confident

Question Title

8. How aware are you of current recommendations regarding evaluation of HER2-neu status in patients with gastric cancer?

Extremely aware

Very aware

Moderately aware

Slightly aware

Not aware at all

Question Title

9. How confident are you in your knowledge of current guidelines for management of gastric cancer?

Extremely confident

Very confident

Moderately confident

Slightly confident

Not at all confident

	Extremely confident	Very confident	Moderately confident	Slightly confident	Not at all confident
Identifying patients at risk for gastric cancer	Identifying patients at risk for gastric cancer Extremely confident	Identifying patients at risk for gastric cancer Very confident	Identifying patients at risk for gastric cancer Moderately confident	Identifying patients at risk for gastric cancer Slightly confident	Identifying patients at risk for gastric cancer Not at all confident
Recognizing symptoms associated with gastric cancer	Recognizing symptoms associated with gastric cancer Extremely confident	Recognizing symptoms associated with gastric cancer Very confident	Recognizing symptoms associated with gastric cancer Moderately confident	Recognizing symptoms associated with gastric cancer Slightly confident	Recognizing symptoms associated with gastric cancer Not at all confident
Coordinating with other clinicians in the development of treatment plans for patients with gastric cancer	Coordinating with other clinicians in the development of treatment plans for patients with gastric cancer Extremely confident	Coordinating with other clinicians in the development of treatment plans for patients with gastric cancer Very confident	Coordinating with other clinicians in the development of treatment plans for patients with gastric cancer Moderately confident	Coordinating with other clinicians in the development of treatment plans for patients with gastric cancer Slightly confident	Coordinating with other clinicians in the development of treatment plans for patients with gastric cancer Not at all confident
Counseling patients with gastric cancer on treatment plans	Counseling patients with gastric cancer on treatment plans Extremely confident	Counseling patients with gastric cancer on treatment plans Very confident	Counseling patients with gastric cancer on treatment plans Moderately confident	Counseling patients with gastric cancer on treatment plans Slightly confident	Counseling patients with gastric cancer on treatment plans Not at all confident

Extremely confident

Very confident

Moderately confident

Slightly confident

Not at all confident

Identifying patients at risk for gastric cancer

Identifying patients at risk for gastric cancer Extremely confident

Identifying patients at risk for gastric cancer Very confident

Identifying patients at risk for gastric cancer Moderately confident

Identifying patients at risk for gastric cancer Slightly confident

Identifying patients at risk for gastric cancer Not at all confident

Recognizing symptoms associated with gastric cancer

Recognizing symptoms associated with gastric cancer Extremely confident

Recognizing symptoms associated with gastric cancer Very confident

Recognizing symptoms associated with gastric cancer Moderately confident

Recognizing symptoms associated with gastric cancer Slightly confident

Recognizing symptoms associated with gastric cancer Not at all confident

Coordinating with other clinicians in the development of treatment plans for patients with gastric cancer

Coordinating with other clinicians in the development of treatment plans for patients with gastric cancer Extremely confident

Coordinating with other clinicians in the development of treatment plans for patients with gastric cancer Very confident

Coordinating with other clinicians in the development of treatment plans for patients with gastric cancer Moderately confident

Coordinating with other clinicians in the development of treatment plans for patients with gastric cancer Slightly confident

Coordinating with other clinicians in the development of treatment plans for patients with gastric cancer Not at all confident

Counseling patients with gastric cancer on treatment plans

Counseling patients with gastric cancer on treatment plans Extremely confident

Counseling patients with gastric cancer on treatment plans Very confident

Counseling patients with gastric cancer on treatment plans Moderately confident

Counseling patients with gastric cancer on treatment plans Slightly confident

Counseling patients with gastric cancer on treatment plans Not at all confident

	Extremely confident	Very confident	Moderately confident	Slightly confident	Not at all confident
Selection of primary surgical intervention for patients with gastric cancer	Selection of primary surgical intervention for patients with gastric cancer Extremely confident	Selection of primary surgical intervention for patients with gastric cancer Very confident	Selection of primary surgical intervention for patients with gastric cancer Moderately confident	Selection of primary surgical intervention for patients with gastric cancer Slightly confident	Selection of primary surgical intervention for patients with gastric cancer Not at all confident
Selection of patients for concurrent chemoradiation	Selection of patients for concurrent chemoradiation Extremely confident	Selection of patients for concurrent chemoradiation Very confident	Selection of patients for concurrent chemoradiation Moderately confident	Selection of patients for concurrent chemoradiation Slightly confident	Selection of patients for concurrent chemoradiation Not at all confident
Selection of patients for postoperative chemotherapy	Selection of patients for postoperative chemotherapy Extremely confident	Selection of patients for postoperative chemotherapy Very confident	Selection of patients for postoperative chemotherapy Moderately confident	Selection of patients for postoperative chemotherapy Slightly confident	Selection of patients for postoperative chemotherapy Not at all confident
Selection of first-line therapy for patients with metastatic gastric cancer	Selection of first-line therapy for patients with metastatic gastric cancer Extremely confident	Selection of first-line therapy for patients with metastatic gastric cancer Very confident	Selection of first-line therapy for patients with metastatic gastric cancer Moderately confident	Selection of first-line therapy for patients with metastatic gastric cancer Slightly confident	Selection of first-line therapy for patients with metastatic gastric cancer Not at all confident
Selection of second-line therapy for patients with metastatic gastric cancer	Selection of second-line therapy for patients with metastatic gastric cancer Extremely confident	Selection of second-line therapy for patients with metastatic gastric cancer Very confident	Selection of second-line therapy for patients with metastatic gastric cancer Moderately confident	Selection of second-line therapy for patients with metastatic gastric cancer Slightly confident	Selection of second-line therapy for patients with metastatic gastric cancer Not at all confident
Selection of patients for palliative or best supportive care	Selection of patients for palliative or best supportive care Extremely confident	Selection of patients for palliative or best supportive care Very confident	Selection of patients for palliative or best supportive care Moderately confident	Selection of patients for palliative or best supportive care Slightly confident	Selection of patients for palliative or best supportive care Not at all confident

Extremely confident

Very confident

Moderately confident

Slightly confident

Not at all confident

Selection of primary surgical intervention for patients with gastric cancer

Selection of primary surgical intervention for patients with gastric cancer Extremely confident

Selection of primary surgical intervention for patients with gastric cancer Very confident

Selection of primary surgical intervention for patients with gastric cancer Moderately confident

Selection of primary surgical intervention for patients with gastric cancer Slightly confident

Selection of primary surgical intervention for patients with gastric cancer Not at all confident

Selection of patients for concurrent chemoradiation

Selection of patients for concurrent chemoradiation Extremely confident

Selection of patients for concurrent chemoradiation Very confident

Selection of patients for concurrent chemoradiation Moderately confident

Selection of patients for concurrent chemoradiation Slightly confident

Selection of patients for concurrent chemoradiation Not at all confident

Selection of patients for postoperative chemotherapy

Selection of patients for postoperative chemotherapy Extremely confident

Selection of patients for postoperative chemotherapy Very confident

Selection of patients for postoperative chemotherapy Moderately confident

Selection of patients for postoperative chemotherapy Slightly confident

Selection of patients for postoperative chemotherapy Not at all confident

Selection of first-line therapy for patients with metastatic gastric cancer

Selection of first-line therapy for patients with metastatic gastric cancer Extremely confident

Selection of first-line therapy for patients with metastatic gastric cancer Very confident

Selection of first-line therapy for patients with metastatic gastric cancer Moderately confident

Selection of first-line therapy for patients with metastatic gastric cancer Slightly confident

Selection of first-line therapy for patients with metastatic gastric cancer Not at all confident

Selection of second-line therapy for patients with metastatic gastric cancer

Selection of second-line therapy for patients with metastatic gastric cancer Extremely confident

Selection of second-line therapy for patients with metastatic gastric cancer Very confident

Selection of second-line therapy for patients with metastatic gastric cancer Moderately confident

Selection of second-line therapy for patients with metastatic gastric cancer Slightly confident

Selection of second-line therapy for patients with metastatic gastric cancer Not at all confident

Selection of patients for palliative or best supportive care

Selection of patients for palliative or best supportive care Extremely confident

Selection of patients for palliative or best supportive care Very confident

Selection of patients for palliative or best supportive care Moderately confident

Selection of patients for palliative or best supportive care Slightly confident

Selection of patients for palliative or best supportive care Not at all confident

	Extremely aware	Very aware	Moderately aware	Slightly aware	Not at all aware
HER2	HER2 Extremely aware	HER2 Very aware	HER2 Moderately aware	HER2 Slightly aware	HER2 Not at all aware
EGFR	EGFR Extremely aware	EGFR Very aware	EGFR Moderately aware	EGFR Slightly aware	EGFR Not at all aware
VEGF	VEGF Extremely aware	VEGF Very aware	VEGF Moderately aware	VEGF Slightly aware	VEGF Not at all aware

Extremely aware

Very aware

Moderately aware

Slightly aware

Not at all aware

HER2

HER2 Extremely aware

HER2 Very aware

HER2 Moderately aware

HER2 Slightly aware

HER2 Not at all aware

EGFR

EGFR Extremely aware

EGFR Very aware

EGFR Moderately aware

EGFR Slightly aware

EGFR Not at all aware

VEGF

VEGF Extremely aware

VEGF Very aware

VEGF Moderately aware

VEGF Slightly aware

VEGF Not at all aware

	Extremely important	Very important	Moderately important	Slightly important	Not at all important
Prior therapy	Prior therapy Extremely important	Prior therapy Very important	Prior therapy Moderately important	Prior therapy Slightly important	Prior therapy Not at all important
Performance status	Performance status Extremely important	Performance status Very important	Performance status Moderately important	Performance status Slightly important	Performance status Not at all important
Age of patient	Age of patient Extremely important	Age of patient Very important	Age of patient Moderately important	Age of patient Slightly important	Age of patient Not at all important
Comorbidities	Comorbidities Extremely important	Comorbidities Very important	Comorbidities Moderately important	Comorbidities Slightly important	Comorbidities Not at all important
Ability to monitor toxicities	Ability to monitor toxicities Extremely important	Ability to monitor toxicities Very important	Ability to monitor toxicities Moderately important	Ability to monitor toxicities Slightly important	Ability to monitor toxicities Not at all important
Patient preferences	Patient preferences Extremely important	Patient preferences Very important	Patient preferences Moderately important	Patient preferences Slightly important	Patient preferences Not at all important

Extremely important

Very important

Moderately important

Slightly important

Not at all important

Prior therapy

Prior therapy Extremely important

Prior therapy Very important

Prior therapy Moderately important

Prior therapy Slightly important

Prior therapy Not at all important

Performance status

Performance status Extremely important

Performance status Very important

Performance status Moderately important

Performance status Slightly important

Performance status Not at all important

Age of patient

Age of patient Extremely important

Age of patient Very important

Age of patient Moderately important

Age of patient Slightly important

Age of patient Not at all important

Comorbidities

Comorbidities Extremely important

Comorbidities Very important

Comorbidities Moderately important

Comorbidities Slightly important

Comorbidities Not at all important

Ability to monitor toxicities

Ability to monitor toxicities Extremely important

Ability to monitor toxicities Very important

Ability to monitor toxicities Moderately important

Ability to monitor toxicities Slightly important

Ability to monitor toxicities Not at all important

Patient preferences

Patient preferences Extremely important

Patient preferences Very important

Patient preferences Moderately important

Patient preferences Slightly important

Patient preferences Not at all important

Gastric Cancer Learner Survey

Question Title

1. To your knowledge, which racial/ethnic group has the highest incidence of gastric cancer?

Question Title

2. To your knowledge, death from gastric cancer is more likely for patients from which racial/ethnic group?

Question Title

3. Which racial/ethnic group has a significantly higher survival rate for gastric cancers, regardless of tumor site, stage, and treatment?

Question Title

4. Which racial/ethnic group has a higher mortality rate for gastric cancers, despite decreasing incidence/mortality of more common cancers, such as breast, prostate, lung, and colorectal?

Question Title

5. To your knowledge, which of the following racial/ethnic groups has the highest rate of Helicobacter pylori-associated gastric cancers?

Question Title

6. How aware are you of the published analysis showing that African-American patients with gastric cancer are significantly less likely to receive adjuvant radiotherapy?

Question Title

7. How confident are you in your knowledge of genetic risk factors for gastric cancer?

Question Title

8. How aware are you of current recommendations regarding evaluation of HER2-neu status in patients with gastric cancer?

Question Title

9. How confident are you in your knowledge of current guidelines for management of gastric cancer?

Question Title

10. How confident are you in the following tasks?

Question Title

11. How confident are you in each of the following?

Question Title

12. Please indicate your level of awareness of potential molecular targets for gastric cancer therapy:

Question Title

13. How important is each of the following in your decision process when selecting second-line therapy for patients with gastric cancer?